Ondansetron
Product Images NDC 67296-0815

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 67296-0815). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Chemical Structure)

FDA Label Image

Showbox4mg (Showbox4mg)

Showbox4mg (Showbox4mg)
This text provides information about NDC 62756-130-02 Ondansetron Hydrochloride Tablets. The tablets contain 4mg of the active ingredient and are available in a packaging of 100 (10x10) Unit Dose Tablets. This medication is for prescription use only.*
FDA Label Image

Showbox8mg (Showbox8mg)

Showbox8mg (Showbox8mg)
This text provides information about Ondansetron Hydrochloride Tablets, each tablet containing 8mg of the active ingredient. The packaging includes 100 unit dose tablets arranged in 10 strips of 10 tablets each. This medication is available by prescription only. The National Drug Code (NDC) for this product is 62756-131-02.*
FDA Label Image

Spl-ondansetron-chemical-structure (Spl Ondansetron Chemical Structure)

FDA Label Image

Spl-ondansetron-hcl-label-4mg (Spl Ondansetron HCl Label 4mg)

Spl-ondansetron-hcl-label-4mg (Spl Ondansetron HCl Label 4mg)
This text provides information on a medication called Ondansetron Hydrochloride tablets containing 5 mg of Onansetron hydrochloride, USP equivalent to 4 mg of Ondansetron. It includes details on the usual dosage, storage conditions, distribution by Sun Pharmaceutical Industries, and manufacturing location in Halol, Gujarat, India. The NDC number and other relevant information are also available.*
FDA Label Image

Spl-ondansetron-hcl-label-8mg (Spl Ondansetron HCl Label 8mg)

Spl-ondansetron-hcl-label-8mg (Spl Ondansetron HCl Label 8mg)
This text provides information about a medication containing 10 mg of ondansetron hydrochloride. The usual dosage and storage instructions are included. The medication is film-coated and is distributed by Sun Pharmaceutical Industries. It is important to store it at 20° to 25°C and protect it from light. The medication is prescribed and should be dispensed in a tight, light-resistant container.*
FDA Label Image

Spl-ondansetron-odt-4mg-showbox (Spl Ondansetron Odt 4mg Showbox)

Spl-ondansetron-odt-4mg-showbox (Spl Ondansetron Odt 4mg Showbox)
This is information about Ondansetron Orally Disintegrating Tablets, USP. Each tablet contains 4 mg ondansetron, USP, and is meant for oral use. It is important to follow the instructions in the package insert for Dosage and Administration. The tablet meets USP Disintegration Test 2 standards. Store the tablets between 20° to 25°C and ensure the blisters are intact before use. The product is manufactured by Sun Pharmaceutical Industries Ltd. in India and distributed by Sun Pharmaceutical Industries, Inc. in the United States.*
FDA Label Image

Spl-ondansetron-odt-8mg-showbox (Spl Ondansetron Odt 8mg Showbox)

Spl-ondansetron-odt-8mg-showbox (Spl Ondansetron Odt 8mg Showbox)
This is a description of Ondansetron Orally Disintegrating Tablets, USP containing 8 mg of ondansetron. The tablets come in a pack of 30 tablets, divided into 3 blister cards of 10 tablets each. It is important to note that these tablets are for oral use only. The package insert should be referred to for dosage and administration instructions. The tablets must be kept in a child-resistant container, and if blisters are torn or broken, they should not be used. The storage temperature should be maintained between 20°C to 25°C. This medication is manufactured by Sun Pharmaceutical Industries Ltd. in Gujarat, India, and distributed by Sun Pharmaceutical Industries, Inc. in Cranbury, NJ.*
FDA Label Image

Spl-ondansetron-odt-label-4mg (Spl Ondansetron Odt Label 4mg)

Spl-ondansetron-odt-label-4mg (Spl Ondansetron Odt Label 4mg)
This text provides information about a medication called Ondansetron. Each tablet contains 4 mg of ondansetron. It indicates that phenylalanine is included in the tablets, making them unsuitable for phenylketonurics. The text suggests referring to the package insert for dosage and administration instructions. It recommends storing the tablets at 20° to 25°C (68° to 77°F) as per USP Controlled Room Temperature guidelines. The medication meets USP Disintegration Test 2 standards. The tablets are distributed by Sun Pharmaceutical Industries, Inc. in Cranbury, NJ with a National Drug Code (NDC) of 62756-240-83. The manufacturing is done by Sun Pharmaceutical Industries Ltd. in Gujarat, India. The text also includes a Global Trade Item Number (GTIN), serial number (SN), lot number, and expiration date format.*
FDA Label Image

Spl-ondansetron-odt-label-8mg (Spl Ondansetron Odt Label 8mg)

Spl-ondansetron-odt-label-8mg (Spl Ondansetron Odt Label 8mg)
This text contains information about a tablet that contains 8 mg of ondansetron, USP, and is for oral disintegration. The tablets also contain phenylalanine and meet the USP Disintegration Test 2. The dosage and administration instructions are provided in the package insert. The tablets should be stored at 20° to 25°C (68° to 77°F). The product is distributed by Sun Pharmaceutical Industries, Inc., and the manufacturing details are provided for reference.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.